Savara, Inc. (SVRA)
5.21
+0.07
(+1.36%)
USD |
NASDAQ |
May 27, 15:00
Savara Free Cash Flow : -106.97M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Spyre Therapeutics, Inc. | -185.87M |
| ACADIA Pharmaceuticals, Inc. | 113.59M |
| Alnylam Pharmaceuticals, Inc. | 641.34M |
| Amgen, Inc. | 8.597B |
| Biogen, Inc. | 2.316B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -33.05M |
| Cash from Investing (Quarterly) | 38.78M |
| Cash from Financing (Quarterly) | -0.195M |
| Free Cash Flow Per Share (Quarterly) | -0.1307 |
| Free Cash Flow to Equity (Quarterly) | -33.30M |
| Free Cash Flow to Firm (Quarterly) | -33.10M |
| Free Cash Flow Yield | -8.86% |